1. Soluble levels of sCD40L and s4‐1BB are associated with a poor prognosis in elderly patients with colorectal cancer
   Petrus M. A. Lima et al, 2020, Journal of Surgical Oncology CrossRef
2. Unlocking the Potential of Therapy-Induced Cytokine Responses: Illuminating New Pathways in Cancer Precision Medicine
   Dilip R. Gunturu et al, 2024, Current Oncology CrossRef
3. Changes in Tumor Immune Microenvironment after Radiotherapy Resistance in Colorectal Cancer: A Narrative Review
   Chao Wang et al, 2023, Oncology Research and Treatment CrossRef
4. Identification of protein clusters predictive of tumor response in rectal cancer patients receiving neoadjuvant chemo-radiotherapy
   Ombretta Repetto et al, 2017, Oncotarget CrossRef
5. Non-operative management of rectal cancer: understanding tumor biology
   Iris H. Wei et al, 2018, Minerva Chirurgica CrossRef
6. Extracellular vesicles mediate low dose ionizing radiation-induced immune and inflammatory responses in the blood
   Tünde Szatmári et al, 2019, International Journal of Radiation Biology CrossRef
7. MicroRNA molecular profiling identifies potential signaling pathways conferring resistance to chemoradiation in locally-advanced rectal adenocarcinoma
   Cory Pettit et al, 2018, Oncotarget CrossRef
8. Biomarqueurs inflammatoires et immunologiques de réponse à la radiothérapie
   J.P. Nesseler et al, 2018, Cancer/Radiothérapie CrossRef
9. Predicting response to neoadjuvant chemoradiotherapy in rectal cancer: from biomarkers to tumor models
   Moying Li et al, 2022, Therapeutic Advances in Medical Oncology CrossRef
10. The Relationship between Inflammation Markers (CRP, IL-6, sCD40L) and Colorectal Cancer Stage, Grade, Size and Location
    Olga Martyna Koper-Lenkiewicz et al, 2021, Diagnostics CrossRef
11. High plasma CD40 ligand level is associated with more advanced stages and worse prognosis in colorectal cancer
    Zoltan Herold et al, 2022, World Journal of Clinical Cases CrossRef
12. Biomarkers and cell-based models to predict the outcome of neoadjuvant therapy for rectal cancer patients
    Aylin Alkan et al, 2021, Biomarker Research CrossRef
13. Evolving notions on immune response in colorectal cancer and their implications for biomarker development
    Fabio Grizzi et al, 2018, Inflammation Research CrossRef
14. High platelet × C-reactive protein level multiplier is a negative prognostic marker in rectal cancer treated by neoadjuvant chemoradiotherapy
    Shozo Ide et al, 2021, International Journal of Clinical Oncology CrossRef
15. The predicting value of postoperative body temperature on long-term survival in patients with rectal cancer
    Huichuan Yu et al, 2015, Tumor Biology CrossRef
16. Tissue-Based Markers as a Tool to Assess Response to Neoadjuvant Radiotherapy in Rectal Cancer—Systematic Review
    Edgaras Smolskas et al, 2022, International Journal of Molecular Sciences CrossRef